Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Nurix Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 101 | 1 | 104 | +4 |
| Shares | 41.3M | 283.3K | 39.5M | −1.53M (−3.7%) |
| Value | $1.29B | $8.81M | $1.05B | −$227.6M (−17.8%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Nurix Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Regents of the University of California | 571,212 | $15.2M | 1.93% |
| UBS Asset Management Americas Inc | 285,880 | $7.58M | 0.00% |
| Clough Capital Partners L P | 168,800 | $4.48M | 0.25% |
| Euclidean Capital LLC | 154,426 | $4.10M | 1.33% |
| Citadel Advisors LLC | 50,671 | $1.34M | 0.00% |
| HarbourVest Partners LLC | 44,141 | $1.17M | 0.11% |
| Raymond James Financial Services Advisors, Inc. | 43,826 | $1.16M | 0.00% |
| Alliancebernstein L.P. | 32,800 | $870.0K | 0.00% |
| AtonRa Partners | 23,611 | $626.0K | 0.23% |
| Invesco Ltd. | 13,484 | $358.0K | 0.00% |
| Hershey Trust Co | 8,807 | $234.0K | 0.00% |
| EMC Capital Management | 8,427 | $224.0K | 0.13% |
| Virtu Financial LLC | 7,574 | $201.0K | 0.02% |
| Virtus ETF Advisers LLC | 7,570 | $201.0K | 0.08% |
| Quantbot Technologies LP | 200 | $5.00K | 0.00% |
| TCI Wealth Advisors, Inc. | 67 | $2.00K | 0.00% |
| Signaturefd, LLC | 26 | $1.00K | 0.00% |
Sold out (13)
Institutions that held Nurix Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| The Column Group LLC | 5,383,333 | $167.4M |
| Pinz Capital Management, LP | 72,459 | $2.25M |
| Hamilton Lane Advisors LLC | 49,533 | $1.54M |
| Bank Julius Baer & Co. Ltd, Zurich | 35,593 | $1.11M |
| JS Capital Management LLC | 29,766 | $925.0K |
| California Public Employees Retirement System | 22,600 | $703.0K |
| American Financial Group Inc | 14,884 | $462.0K |
| Trexquant Investment LP | 12,337 | $384.0K |
| Laurion Capital Management LP | 7,000 | $218.0K |
| Exane Derivatives | 2,300 | $71.5K |
| STRS Ohio | 2,200 | $68.0K |
| Pacer Advisors, Inc. | 1,581 | $49.0K |
| Bank of Montreal | 709 | $23.0K |
Not filed for Q2 2021 yet (1)
Institutions that held Nurix Therapeutics, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| WestHill Financial Advisors, Inc. | 283,333 | $8.81M |